<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Addict Sci Clin Pract</journal-id><journal-id journal-id-type="iso-abbrev">Addict Sci Clin Pract</journal-id><journal-id journal-id-type="pmc-domain-id">1002</journal-id><journal-id journal-id-type="pmc-domain">ascp</journal-id><journal-title-group><journal-title>Addiction Science &amp; Clinical Practice</journal-title></journal-title-group><issn pub-type="ppub">1940-0632</issn><issn pub-type="epub">1940-0640</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10041696</article-id><article-id pub-id-type="pmcid-ver">PMC10041696.1</article-id><article-id pub-id-type="pmcaid">10041696</article-id><article-id pub-id-type="pmcaiid">10041696</article-id><article-id pub-id-type="pmid">36967381</article-id><article-id pub-id-type="doi">10.1186/s13722-023-00376-z</article-id><article-id pub-id-type="publisher-id">376</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>A systematic review of substance use screening in outpatient behavioral health settings</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Woodward</surname><given-names initials="D">Diana</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilens</surname><given-names initials="TE">Timothy E.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Glantz</surname><given-names initials="M">Meyer</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rao</surname><given-names initials="V">Vinod</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Burke</surname><given-names initials="C">Colin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2409-9426</contrib-id><name name-style="western"><surname>Yule</surname><given-names initials="AM">Amy M.</given-names></name><address><email>amy.yule@bmc.org</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution>Department of Psychiatry, </institution><institution>Massachusetts General Hospital, Harvard Medical School, </institution></institution-wrap>Boston, MA 02114 USA </aff><aff id="Aff2"><label>2</label>Private Clinical Practice, Rockville, MD USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.239424.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2183 6745</institution-id><institution>Department of Psychiatry, </institution><institution>Boston Medical Center, </institution></institution-wrap>850 Harrison Avenue, Boston, MA 02118 USA </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>3</month><year>2023</year></pub-date><pub-date pub-type="ppub"><year>2023</year></pub-date><volume>18</volume><issue-id pub-id-type="pmc-issue-id">424967</issue-id><elocation-id>18</elocation-id><history><date date-type="received"><day>25</day><month>8</month><year>2022</year></date><date date-type="accepted"><day>15</day><month>3</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>03</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>28</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-03-28 00:10:13.037"><day>28</day><month>03</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="13722_2023_Article_376.pdf"/><abstract id="Abs1"><sec><title>Objective</title><p id="Par1">Despite the frequent comorbidity of substance use disorders (SUDs) and psychiatric disorders, it remains unclear if screening for substance use in behavioral health clinics is a common practice. The aim of this review is to examine what is known about systematic screening for substance use in outpatient behavioral health clinics.</p></sec><sec><title>Methods</title><p id="Par2">We conducted a PRISMA-based systematic literature search assessing substance use screening in outpatient adult and pediatric behavioral health settings in PubMed, Embase, and PsycINFO. Quantitative studies published in English before May 22, 2020 that reported the percentage of patients who completed screening were included.</p></sec><sec><title>Results</title><p id="Par3">Only eight articles met our inclusion and exclusion criteria. Reported prevalence of screening ranged from 48 to 100%, with half of the studies successfully screening more than 75% of their patient population. There were limited data on patient demographics for individuals who were and were not screened (e.g., gender, race) and screening practices (e.g., electronic versus paper/pencil administration).</p></sec><sec><title>Conclusions</title><p id="Par4">The results of this systematic review suggest that successful screening for substance use in behavioral health settings is possible, yet it remains unclear how frequently screening occurs. Given the high rates of comorbid SUD and psychopathology, future research is necessary regarding patient and clinic-level variables that may impact the successful implementation of substance use screening.</p><p id="Par5"><italic toggle="yes">Trial registry</italic> A methodological protocol was registered with the PROSPERO systematic review protocol registry (ID: CRD42020188645).</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13722-023-00376-z.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Screening</kwd><kwd>Substance use</kwd><kwd>Substance use disorder</kwd><kwd>Behavioral health</kwd><kwd>Outpatient</kwd></kwd-group><funding-group><award-group><funding-source><institution>National Institutes of Health (US)</institution></funding-source><award-id>4UH3DA050252-0</award-id><principal-award-recipient><name name-style="western"><surname>Yule</surname><given-names>Amy M.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par16">Substance use disorders (SUD) pose a substantial societal burden in the United States. In 2020 alone, an estimated 28.3 million people aged 12 or older met criteria for a past-year alcohol use disorder, while 18.4 million people aged 12 or older experienced a past-year illicit drug use disorder [<xref ref-type="bibr" rid="CR1">1</xref>] Risky substance use and SUD are associated with substantial disability and mortality, with an estimated 480000 tobacco-related deaths and 95000 alcohol-related deaths annually in the United States [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Of particular concern, drug-related overdose deaths have risen over the past years, increasing from 70,630 deaths in 2019 to 92000 deaths in 2020 [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par17">Prior research has established psychopathology as a significant risk factor for developing a SUD [<xref ref-type="bibr" rid="CR6">6</xref>&#8211;<xref ref-type="bibr" rid="CR9">9</xref>]. For example, individuals with depression are approximately 2 times more likely to develop a SUD, and those with attention deficit hyperactivity disorder exhibit a 2.3 times greater risk [<xref ref-type="bibr" rid="CR10">10</xref>]. Furthermore, individuals with one or more psychiatric diagnoses experience greater SUD severity [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. The sequelae of co-occurring SUD and psychiatric disorders include increased odds of additional psychopathology [<xref ref-type="bibr" rid="CR15">15</xref>], hospitalizations [<xref ref-type="bibr" rid="CR16">16</xref>], suicide attempts [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], overdose [<xref ref-type="bibr" rid="CR19">19</xref>&#8211;<xref ref-type="bibr" rid="CR21">21</xref>], criminal behavior [<xref ref-type="bibr" rid="CR22">22</xref>], and homelessness [<xref ref-type="bibr" rid="CR23">23</xref>]. Additionally, adults with co-occurring disorders report overall lower quality of life [<xref ref-type="bibr" rid="CR24">24</xref>] and lower social and occupational functioning [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par18">Despite the imposed burden of comorbid SUD and psychopathology, in 2019, 51.4% of individuals in the United States with co-occurring disorders received no treatment, 38.7% received mental health treatment only, 7.8% received treatment for both mental health and SUD, and 1.9% received SUD treatment only (27). Given that many treatment-seeking individuals with co-occurring SUD and psychopathology obtain mental health treatment rather than substance use treatment, screening for substance use concerns in behavioral health settings is necessary to identify individuals at the greatest risk for maladaptive outcomes.</p><p id="Par19">To this end, both the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute for Health and Clinical Guidance (NICE) have urged mental health providers to routinely administer patient self-report questionnaires to screen for substance use [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Most efforts to integrate substance use screening into clinical care have focused on primary care settings [<xref ref-type="bibr" rid="CR30">30</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref>]. As such, the success of substance use screening tools in other outpatient settings remains unclear. Because behavioral health clinics generally have both fewer ancillary supports to assist with screening compared to primary care, as well as high staff turnover rates [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], research is needed on screening for substance use in these settings. Hence, we aim to summarize the extant literature on systematic screening for substance use in behavioral health, with a focus on the prevalence of screening within these clinics, characteristics of the screening tools used, and screening practices.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par20">A methodological protocol was registered with the PROSPERO systematic review protocol registry (ID: CRD42020188645).</p><sec id="Sec3"><title>Search strategy</title><p id="Par21">We conducted a search based upon Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines of peer-reviewed literature within the PubMed, Embase, and PsycINFO databases through May 22, 2020 with no restrictions for the start date. We examined both the prevalence and frequency of substance use screening in outpatient behavioral health clinics as well as the characteristics of the outpatient behavioral health clinics that screen for substance use. We searched each database using various combinations of search terms that can be found in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>. Bibliographies of reviewed articles were also examined for additional studies to ensure that no relevant articles were omitted.</p><p id="Par22">Inclusion criteria were quantitative studies examining substance use screening in outpatient adult and pediatric behavioral health clinics published in English. This included general psychiatric clinics, community mental health organizations, university counseling centers, and other specialty services. Studies were only included if they implemented systematic screening for substance use and reported the percentage of patients who completed the screener. Editorials, commentaries, opinion papers, chapters, and research studies that recruited participants to complete screening tools were excluded. Studies examining screening for substance use only in integrated behavioral health settings within primary care, emergency rooms, or inpatient settings were also excluded. If studies examined screening for substance use in behavioral health-only clinics alongside integrated behavioral health settings they were included if they stratified screening rates by clinic type.</p></sec><sec id="Sec4"><title>Selection of studies</title><p id="Par23">Two reviewers independently screened the titles and abstracts of all papers. Any disagreements were resolved by consensus, and irrelevant titles were excluded. A record was kept of all irrelevant and duplicate articles. The full text of the remaining papers was reviewed by the two investigators and included/excluded. A third senior investigator reviewed all the included papers to confirm they met inclusion/exclusion criteria.</p></sec><sec id="Sec5"><title>Data extraction, analysis, and synthesis</title><p id="Par24">Data were extracted from the quantitative studies by one reviewer and discussed with the senior reviewer. The following variables were extracted: Setting, sample size, percentage of patients screened, patient demographics, language of screening tool, screener administered, substances screened, date of study, frequency of screening, and method of screening (computer, paper, self-report, clinician report, etc.).</p></sec></sec><sec id="Sec6"><title>Results</title><p id="Par25">Our initial search yielded 362 non-duplicate articles&#160;(Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Eighty-four articles were determined to be potentially relevant and therefore reviewed in full. Of the 84 potentially relevant articles, 76 articles were excluded based on eligibility criteria (see Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Eight articles were included in the final review&#160;(Table <xref rid="Tab1" ref-type="table">1</xref>). The most common reasons for exclusion after full-text review were that the article reported on data from a sample recruited for a research study (N&#8201;=&#8201;23), the authors did not report the percentage of patients screened (N&#8201;=&#8201;13), or screening was implemented in a non-behavioral health setting (N&#8201;=&#8201;11). The 8 articles included in this systematic review were published between 1992 and 2018. The sample sizes ranged from 88 to 22,956 screened patients.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>PRISMA diagram</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="13722_2023_376_Fig1_HTML.jpg"/></fig><table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Studies reporting systematic screening for substance use in outpatient behavioral health settings</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Author, Year</th><th align="left" colspan="1" rowspan="1">Setting description (number of settings, pediatric/adult)</th><th align="left" colspan="1" rowspan="1">Screener</th><th align="left" colspan="1" rowspan="1">Substances Screened</th><th align="left" colspan="1" rowspan="1">Frequency of Screening</th><th align="left" colspan="1" rowspan="1">Administration</th><th align="left" colspan="1" rowspan="1">Method of Screening</th><th align="left" colspan="1" rowspan="1">% Screened</th><th align="left" colspan="1" rowspan="1">N (screened)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Denering and Spear, 2012</td><td align="left" colspan="1" rowspan="1">University counseling center (1, adult)</td><td align="left" colspan="1" rowspan="1">AUDIT-C* (prescreen) ASSIST* (screen)</td><td align="left" colspan="1" rowspan="1">AUDIT-C*: Alcohol ASSIST*: Tobacco, alcohol, cannabis, cocaine, amphetamine, inhalants, sedatives, hallucinogens, opioids, other drugs</td><td align="left" colspan="1" rowspan="1">Intake</td><td align="left" colspan="1" rowspan="1">AUDIT-C*: self ASSIST*: clinician</td><td align="left" colspan="1" rowspan="1">Not Reported</td><td align="left" colspan="1" rowspan="1">100.0%</td><td align="left" colspan="1" rowspan="1">AUDIT-C*: 6,772 ASSIST*: 1534</td></tr><tr><td align="left" colspan="1" rowspan="1">Gabel, Radigan, Wang and Sederer, 2011</td><td align="left" colspan="1" rowspan="1">Outpatient and day treatment (48, pediatric)</td><td align="left" colspan="1" rowspan="1">CRAFFT Single cigarette use question Single drug use question</td><td align="left" colspan="1" rowspan="1">Cigarettes, alcohol, "street " drugs</td><td align="left" colspan="1" rowspan="1">CRAFFT: intake and 1&#160;year Single cigarette and drug question: quarterly</td><td align="left" colspan="1" rowspan="1">Self</td><td align="left" colspan="1" rowspan="1">Not Reported</td><td align="left" colspan="1" rowspan="1">Smoking: 85.0% Alcohol/drug: 84.0%</td><td align="left" colspan="1" rowspan="1">2095</td></tr><tr><td align="left" colspan="1" rowspan="1">Karno, Granholmm and Lin, 2000</td><td align="left" colspan="1" rowspan="1">Outpatient Veterans Affairs Mental Health Clinic (1, adult)</td><td align="left" colspan="1" rowspan="1">AUDIT* CAGE*</td><td align="left" colspan="1" rowspan="1">Alcohol, "drug use"</td><td align="left" colspan="1" rowspan="1">Intake</td><td align="left" colspan="1" rowspan="1">Self</td><td align="left" colspan="1" rowspan="1">Paper</td><td align="left" colspan="1" rowspan="1">74.9%</td><td align="left" colspan="1" rowspan="1">197</td></tr><tr><td align="left" colspan="1" rowspan="1">King, Beehler, Wade, Buchholz, Funderburk, Lilienthal and Vair, 2018</td><td align="left" colspan="1" rowspan="1">Veterans Affairs outpatient and integrated care (Not Reported)</td><td align="left" colspan="1" rowspan="1">AUDIT-C* CAGE*</td><td align="left" colspan="1" rowspan="1">Alcohol</td><td align="left" colspan="1" rowspan="1">Intake</td><td align="left" colspan="1" rowspan="1">Not Reported</td><td align="left" colspan="1" rowspan="1">Not Reported</td><td align="left" colspan="1" rowspan="1">AUDIT-C: 80.4% CAGE: 00.0%</td><td align="left" colspan="1" rowspan="1">22,956 at least 1 screen</td></tr><tr><td align="left" colspan="1" rowspan="1">Ramo, Bahorik, Delucchi, Campbell and Satre, 2018</td><td align="left" colspan="1" rowspan="1">Outpatient and partial hospitalization (2, adult)</td><td align="left" colspan="1" rowspan="1">ASSIST*</td><td align="left" colspan="1" rowspan="1">Tobacco, alcohol, marijuana, prescription sedative/ hypnotic pills, cocaine, amphetamines, opioids, hallucinogens, ecstasy/ MDMA</td><td align="left" colspan="1" rowspan="1">Intake</td><td align="left" colspan="1" rowspan="1">Self</td><td align="left" colspan="1" rowspan="1">Computer</td><td align="left" colspan="1" rowspan="1">48.0%</td><td align="left" colspan="1" rowspan="1">405</td></tr><tr><td align="left" colspan="1" rowspan="1">Satre, Wolfe, Eisendrath and Weisner, 2008</td><td align="left" colspan="1" rowspan="1">Outpatient (1, adult)</td><td align="left" colspan="1" rowspan="1">Electronic Health Inventory If positive: SMAST*</td><td align="left" colspan="1" rowspan="1">Alcohol, cannabis, cocaine, amphetamines, hallucinogens, ecstasy, sedatives opioids, and tobacco</td><td align="left" colspan="1" rowspan="1">Intake</td><td align="left" colspan="1" rowspan="1">Self</td><td align="left" colspan="1" rowspan="1">Computer</td><td align="left" colspan="1" rowspan="1">75.0%</td><td align="left" colspan="1" rowspan="1">422</td></tr><tr><td align="left" colspan="1" rowspan="1">Silverman, O'Neill, Cleary, Barwick and Joseph, 1992</td><td align="left" colspan="1" rowspan="1">Outpatient (1, adult)</td><td align="left" colspan="1" rowspan="1">SMAST*</td><td align="left" colspan="1" rowspan="1">Alcohol</td><td align="left" colspan="1" rowspan="1">Intake</td><td align="left" colspan="1" rowspan="1">Self</td><td align="left" colspan="1" rowspan="1">Not Reported</td><td align="left" colspan="1" rowspan="1">88.0%</td><td align="left" colspan="1" rowspan="1">88</td></tr><tr><td align="left" colspan="1" rowspan="1">Stanhope, Manuel, Jessell and Halliday, 2018</td><td align="left" colspan="1" rowspan="1">Community health organizations (27, adult)</td><td align="left" colspan="1" rowspan="1">CRAFFT UNCOPE</td><td align="left" colspan="1" rowspan="1">Alcohol, marijuana, &#8220;anything else to get high&#8221;</td><td align="left" colspan="1" rowspan="1">Not Reported</td><td align="left" colspan="1" rowspan="1">Not Reported</td><td align="left" colspan="1" rowspan="1">Not Reported</td><td align="left" colspan="1" rowspan="1">93.5%</td><td align="left" colspan="1" rowspan="1">2873</td></tr></tbody></table><table-wrap-foot><p>* Screener abbreviations</p><p><italic toggle="yes">AUDIT</italic> alcohol use disorders identification test; <italic toggle="yes">CAGE</italic> cut down, annoyed, guilty, eye opener;&#160;<italic toggle="yes">ASSIST</italic> alcohol, smoking and substance involvement screening test;&#160;<italic toggle="yes">SMAST</italic> short michigan alcoholism screening test</p></table-wrap-foot></table-wrap></p><sec id="Sec7"><title>Setting</title><p id="Par26">Six of the eight studies were conducted in behavioral health clinics within a larger healthcare system, two of which took place in Veterans Affairs (VA) facilities [<xref ref-type="bibr" rid="CR36">36</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref>]. The two studies that were not conducted in healthcare systems were conducted in a university counseling center [<xref ref-type="bibr" rid="CR42">42</xref>] and community mental health organizations [<xref ref-type="bibr" rid="CR43">43</xref>]. All studies were conducted in the United States. Four studies were single-site [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR40">40</xref>&#8211;<xref ref-type="bibr" rid="CR42">42</xref>], three studies included multiple sites ranging from 2 to 48 [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], and one study did not report the number of sites [<xref ref-type="bibr" rid="CR38">38</xref>]. The majority of the studies (62.5%) were conducted in adult clinics [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR44">44</xref>], with one study focused on college students [<xref ref-type="bibr" rid="CR42">42</xref>]. Two studies included pediatric patients [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], and one study did not report age [<xref ref-type="bibr" rid="CR41">41</xref>].</p></sec><sec id="Sec8"><title>Screener and substances screened</title><p id="Par27">All of the studies screened for alcohol, the majority screened for drugs (N&#8201;=&#8201;6) [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], and half of the studies screened for tobacco (N&#8201;=&#8201;4) [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Of those that screened for drugs, two studies administered screeners which did not differentiate type of substance [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Of the remaining four, all specifically queried about marijuana/cannabis [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], and three screened for other drugs, including opioids [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. A range of 1 to 5 screeners was used to assess for substance use. Additionally, one study administered both a pre-screening instrument and a screening instrument [<xref ref-type="bibr" rid="CR42">42</xref>]. The most commonly used screeners were the Alcohol Use Disorders Identification Test-Concise (AUDIT-C) [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR45">45</xref>], the CRAFFT [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR47">47</xref>], and the Short Michigan Alcohol Screening Test (SMAST) [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] (all N&#8201;=&#8201;2).</p></sec><sec id="Sec9"><title>Frequency and methods of screening</title><p id="Par28">The majority of studies reported screening only at intake (N&#8201;=&#8201;6) [<xref ref-type="bibr" rid="CR37">37</xref>&#8211;<xref ref-type="bibr" rid="CR42">42</xref>]. One clinic implemented different screening instruments at intake, quarterly, and one year [<xref ref-type="bibr" rid="CR36">36</xref>], and Stanhope et al. did not report the frequency of their screening across community mental health organizations. Of the eight studies, five relied solely on self-administration [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR39">39</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref>], one on both self- (prescreen) and clinician- (screen) administration [<xref ref-type="bibr" rid="CR42">42</xref>], and two did not report how the screening was administered [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Additionally, although the majority (N&#8201;=&#8201;5) of authors did not report how information was collected [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR41">41</xref>&#8211;<xref ref-type="bibr" rid="CR43">43</xref>], two studies utilized an electronic screen [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>] and one study relied on paper and pencil [<xref ref-type="bibr" rid="CR37">37</xref>]. Finally, none of the studies reported the language of their screening instrument(s) [<xref ref-type="bibr" rid="CR37">37</xref>].</p></sec><sec id="Sec10"><title>Screening rate</title><p id="Par29">One study reported screening all patients [<xref ref-type="bibr" rid="CR42">42</xref>]. The screening rates of the remaining studies ranged from 48 to 93.5% of patients. Screening in adult-only clinics ranged from 48 to 100% of patients [<xref ref-type="bibr" rid="CR37">37</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>] while screening from clinics with adult and pediatric patients ranged from 84 to 93.5% [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. The screening rate using an electronic screen ranged from 48 to 75% of patients [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>], and the rate for paper/pencil was 74.9%.</p></sec><sec id="Sec11"><title>Demographics</title><sec id="Sec12"><title>Gender</title><p id="Par30">Five studies reported on the gender of screened patients [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], and one study reported on gender across the total study population (patients who did and did not complete the screening) [<xref ref-type="bibr" rid="CR38">38</xref>]. Of those that reported on the gender of screened patients, the range was 30 to 86% male. In two studies that did not report the gender across the total study population, the studies did report that there were no significant gender differences between patients who did and did not complete screening [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>].</p></sec><sec id="Sec13"><title>Age</title><p id="Par31">Four studies reported the mean age of screened patients, with a range of 16.6 to 42.9&#160;years [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Three studies reported mean age across the total study population, with a range of 36.1 to 53.5&#160;years [<xref ref-type="bibr" rid="CR38">38</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref>]. One additional study that did not report mean age across the total study population reported no significant difference in mean age between screened patients and the total study population [<xref ref-type="bibr" rid="CR43">43</xref>].</p></sec><sec id="Sec14"><title>Race</title><p id="Par32">The three studies that reported on the race of screened patients included predominantly white patients, with these participants ranging from 52.8 to 72% of the sample [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. The next most represented race was Asian, ranging from 9 to 10.5% of the sample. No studies reported race across the total study population; however, two studies reported no significant racial differences between patients who did and did not complete screening [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>].</p></sec><sec id="Sec15"><title>Ethnicity</title><p id="Par33">The two studies that reported on the ethnicity of screened patients included predominantly non-Hispanic patients, with these patients ranging from 73 to 93% of the sample [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. The one study that reported ethnicity across the total study population (patients who did and did not complete screening) was also largely non-Hispanic (94.2%) [<xref ref-type="bibr" rid="CR38">38</xref>]. Two additional studies reported no significant differences in ethnicity between patients who did and did not complete screening; however, they did not report ethnicity type for the study population [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>].</p></sec><sec id="Sec16"><title>Psychiatric comorbidities</title><p id="Par34">Though two studies provided descriptive information on psychopathology, neither compared psychopathology between those who were and were not screened in the clinic [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Karno et al. reported rates of depressive disorder (48%), anxiety disorder (15%), bipolar disorder (13%), and schizophrenia/ schizoaffective disorder (11%) in screened patients. King and colleagues found that 15.1% of all clinic patients had a trauma/ stressor-related disorder (including post-traumatic stress disorder), and 12.9% of all clinic patients had a mood disorder.</p></sec></sec></sec><sec id="Sec17"><title>Conclusions</title><p id="Par35">Our aim in this review was to determine the prevalence and the characteristics of screening practices for substance use in outpatient behavioral health clinics. Though we identified only 8 studies that met review criteria, half of these studies reported screening more than 75% of their patient population [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR41">41</xref>&#8211;<xref ref-type="bibr" rid="CR43">43</xref>].</p><p id="Par36">The screening rates in the identified studies are comparable to those reported in a recent examination of substance use screening in primary care settings, which found that 71.8% of eligible patients were screened after implementation efforts [<xref ref-type="bibr" rid="CR49">49</xref>]. However, whether existing research on screening for substance use represents standard practice in all behavioral health clinics remains unclear given limited reporting on this practice. While the 2020 National Mental Health Services Survey (N-MHSS) reported that approximately 54% of the 4,941 surveyed outpatient mental health treatment facilitates offer screening for tobacco use, it did not specify whether this screening is systematic and routine and did not report on screening for non-nicotine substances (50). Furthermore, the intent to screen for substance use does not always translate into clinical practice. A large survey found that although 93.1% and 78.9% of mental health clinic directors reported having screening guidelines for alcohol and illicit substance use, respectively, only 66.6% and 57.8% of clinic staff reported conducting said screening [<xref ref-type="bibr" rid="CR51">51</xref>].</p><p id="Par37">Several patient- and clinic-level variables influence the successful implementation of systematic screening. Unfortunately, few studies in the current review reported patient demographic information. We were therefore unable to identify specific patient demographics associated with a high prevalence of screening for substance use or demographic differences between patients who were and were not screened to help identify patient groups who did not complete screening. This is notable since research from the primary care setting has found differences in screening for substance use based on demographics. For example, Black and Hispanic patients and adults over the age of 65 may require more assistance to complete electronic screening for substance use due to problems with comprehension or technical issues [<xref ref-type="bibr" rid="CR52">52</xref>]. In light of increasing overdose deaths among Black and Hispanic youth [<xref ref-type="bibr" rid="CR53">53</xref>], research examining the barriers to screening for substance use in particular demographic groups is needed to ensure equitable care.</p><p id="Par38">Clinic factors that influence the successful implementation of screening center around the method of screening administration. For most studies in our review, screening tools were administered as patient self-report [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR39">39</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref>]. This is consistent with recent research in primary care and emergency department settings showing increased patient comfort with self-report screening compared to clinician-administered screening [<xref ref-type="bibr" rid="CR54">54</xref>&#8211;<xref ref-type="bibr" rid="CR56">56</xref>], particularly amongst individuals who belong to groups who are more stigmatized for substance use [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Another notable finding of our review was the omission of data regarding screening tools (paper and pencil versus electronic) and language of screening. A review of screening in primary care found that electronic questionnaires using patient self-report in both pediatric and adult settings improved data quality and completion time, decreased costs, and were preferred by patients. However, the use of electronic questionnaires also led to increased privacy concerns and access challenges [<xref ref-type="bibr" rid="CR59">59</xref>]. Electronic measures, particularly those linked to the electronic medical record, may also result in racial and ethnic disparities in screening completion rates [<xref ref-type="bibr" rid="CR60">60</xref>]. Additional research in the behavioral health setting is needed to determine patient and clinician preferences regarding the method of screening, particularly for more stigmatized conditions such as substance use [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>].</p><p id="Par39">Finally, the timing and frequency of screening is another important factor to consider during implementation. Most studies in our systematic review reported screening patients for substance use only at intake [<xref ref-type="bibr" rid="CR36">36</xref>&#8211;<xref ref-type="bibr" rid="CR43">43</xref>]. Although screening at intake identifies patients who may benefit from SUD treatment [<xref ref-type="bibr" rid="CR63">63</xref>], ongoing screening and progress monitoring improves engagement in SUD treatment and SUD outcomes [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>], and a recent consensus panel organized by SAMHSA recommended screening patients with psychiatric disorders for substance use annually [<xref ref-type="bibr" rid="CR66">66</xref>]. Thus, future research should examine the prevalence and success of repeated screening for substance use.</p><p id="Par40">The results of our review need to be considered in light of methodological limitations. The generalizability of the findings may be limited given the small number of eligible manuscripts. Moreover, several of these studies were missing information on patient- and clinic-level variables related to implementation that was recently identified as necessary to report on for studies evaluating the use of patient self-report questionnaires to improve the methodological quality, transparency, and applicability of the findings [<xref ref-type="bibr" rid="CR67">67</xref>]. Hence it was difficult to conclude what variables contributed to the successful implementation of screening for substance use in the behavioral health setting. Furthermore, of those studies that did report patient demographics, the majority of the subjects were adults, white, and non-Hispanic. As such, the results may not be generalizable to pediatric or more diverse racial and ethnic groups. Additionally, to narrow the scope of the current review, we excluded manuscripts that examined substance use screening in integrated behavioral health clinics within primary care. Although implementation in these settings is important to investigate to better understand the overall landscape of screening for substance use in settings that provide behavioral health care, integrated behavioral health clinics likely face different barriers and facilitators. Lastly, more clinics may be systematically screening for substance use and not reporting their findings in published results. Thus, this topic is at risk for publication bias as behavioral health clinics that have struggled to implement systematic screening for substance use may not pursue publication.</p><p id="Par41">In summary, the results of our review indicate that screening for substance use in the outpatient behavioral health setting can be successfully implemented at initial intake. Our review highlights the need for further examination of patient- and clinic-level variables that may impact the successful implementation of screening in behavioral health. Future research should include these variables to inform implementation efforts, ensure equity in screening, and achieve consistency with recent reporting guidelines [<xref ref-type="bibr" rid="CR67">67</xref>].</p></sec><sec sec-type="supplementary-material"><title>Supplementary Information</title><sec id="Sec18"><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13722_2023_376_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p><bold>Additional file 1</bold>. Search terms used in the systematic review of substance use screening in outpatient behavioral health settings.</p></caption></media></supplementary-material></p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>SUD</term><def><p id="Par6">Substance use disorder</p></def></def-item><def-item><term>SAMHSA</term><def><p id="Par7">Substance Abuse and Mental Health Services Administration</p></def></def-item><def-item><term>NICE</term><def><p id="Par8">National Institute for Health and Clinical Guidance</p></def></def-item><def-item><term>PRISMA</term><def><p id="Par9">Preferred reporting items for systematic reviews and meta-analyses</p></def></def-item><def-item><term>VA</term><def><p id="Par10">Veterans affairs</p></def></def-item><def-item><term>AUDIT</term><def><p id="Par11">Alcohol use disorders identification test</p></def></def-item><def-item><term>CRAFFT</term><def><p id="Par12">Car, relax, alone, forget, friends, trouble</p></def></def-item><def-item><term>ASSIST</term><def><p id="Par13">Alcohol, smoking and substance involvement screening test</p></def></def-item><def-item><term>SMAST</term><def><p id="Par14">Short Michigan alcohol screening test</p></def></def-item><def-item><term>N-MHSS</term><def><p id="Par15">National Mental Health Services Survey</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We would like to acknowledge Melissa Lydston for her essential role in developing our search terms. We would like to acknowledge Sylvia Lanni for her important role in reviewing and editing our manuscript.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>DW, TW, VR, and AY contributed to the development of the study protocol. DW screened the titles and abstracts of all papers. TW and AY reviewed included papers. VR extracted data from quantitative studies. All authors provided contributions to the writing of the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>AY and TW received funding for this project from the National Institutes of Health through the NIH HEAL Initiative under award number 4UH3DA050252-0. In addition, AY was supported by&#160;research funding from the AACAP-NIDA Career Development Award in Substance Use Research (K12), Award Number 5K12DA000357-17,&#160;Boston University Doris Duke Charitable Foundation&#8217;s Fund to Retain Clinical Scientists, and a Boston University Clinical and Translational Science Institute voucher. She also has funding for clinical program development from the Jack Satter Foundation. CB receives funding from the Harvard Medical School Zinberg Fellowship in Addiction Psychiatry Research, the Massachusetts General Hospital Louis V. Gerstner Research Scholarship, and the AACAP-NIDA Career Development Award in Substance Use Research (K12), Award Number 3K12DA000357-22S1.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this published article [and its Additional information files].</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par42">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par43">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par44">AY is a consultant to the Gavin House and BayCove Human Services (clinical services), as well as the American Psychiatric Association's Providers Clinical Support System Sub-Award. TW has been a consultant for Neurovance/Otsuka, Ironshore, KemPharm, and Vallon, and he has a licensing agreement with Ironshore for a copyrighted diagnostic questionnaire that he co-owns (Before School Functioning Questionnaire). TW also serves as a clinical consultant to the US National Football League (ERM Associates), US Minor/Major League Baseline, Phoenix House/Gavin Foundation, and Bay Cove Human Services. There are no disclosures to report for the remaining authors.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. 2020;156. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf">https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf</ext-link>. Accessed 14 July 2022.</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esser</surname><given-names>MB</given-names></name><name name-style="western"><surname>Sherk</surname><given-names>A</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Naimi</surname><given-names>TS</given-names></name><name name-style="western"><surname>Stockwell</surname><given-names>T</given-names></name><name name-style="western"><surname>Stahre</surname><given-names>M</given-names></name><etal/></person-group><article-title>Deaths and years of potential life lost from excessive alcohol use&#8212;United States, 2011&#8211;2015</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2020</year><volume>69</volume><issue>39</issue><fpage>1428</fpage><lpage>1433</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6939a6</pub-id><pub-id pub-id-type="pmid">33001874</pub-id><pub-id pub-id-type="pmcid">PMC7537556</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking&#8212;50 years of progress: a report of the surgeon general. centers for disease control and prevention (US). 2014. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK179276/">https://www.ncbi.nlm.nih.gov/books/NBK179276/</ext-link>. Accessed 2 Aug. 2022.<pub-id pub-id-type="pmid">24455788</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts national center for health statistics. 2022. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm">https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm</ext-link>. Accessed 2 June 2022.</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Multiple Cause of Death 1999&#8211;2019 on CDC WONDER Online Database. Centers for disease control and prevention, national center for health statistics. 2020 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm">https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm</ext-link>. Accessed 18 May 2021.</mixed-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>HD</given-names></name><name name-style="western"><surname>Fava</surname><given-names>M</given-names></name></person-group><article-title>Order of onset of substance abuse and depression in a sample of depressed outpatients</article-title><source>Compr Psychiatry</source><year>1999</year><volume>40</volume><issue>1</issue><fpage>44</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/s0010-440x(99)90076-7</pub-id><pub-id pub-id-type="pmid">9924877</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kessler</surname><given-names>RC</given-names></name></person-group><article-title>The epidemiology of dual diagnosis</article-title><source>Biol Psychiatry</source><year>2004</year><volume>56</volume><issue>10</issue><fpage>730</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2004.06.034</pub-id><pub-id pub-id-type="pmid">15556117</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merikangas</surname><given-names>KR</given-names></name><name name-style="western"><surname>McClair</surname><given-names>VL</given-names></name></person-group><article-title>Epidemiology of substance use disorders</article-title><source>Hum Genet</source><year>2012</year><volume>131</volume><issue>6</issue><fpage>779</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1007/s00439-012-1168-0</pub-id><pub-id pub-id-type="pmid">22543841</pub-id><pub-id pub-id-type="pmcid">PMC4408274</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilens</surname><given-names>TE</given-names></name><name name-style="western"><surname>Martelon</surname><given-names>M</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>G</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>C</given-names></name><name name-style="western"><surname>Fried</surname><given-names>R</given-names></name><name name-style="western"><surname>Petty</surname><given-names>C</given-names></name><etal/></person-group><article-title>Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD</article-title><source>J Am Acad Child Adolesc Psychiatry</source><year>2011</year><volume>50</volume><issue>6</issue><fpage>543</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1016/j.jaac.2011.01.021</pub-id><pub-id pub-id-type="pmid">21621138</pub-id><pub-id pub-id-type="pmcid">PMC3104208</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Groenman</surname><given-names>AP</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>TWP</given-names></name><name name-style="western"><surname>Oosterlaan</surname><given-names>J</given-names></name></person-group><article-title>Childhood psychiatric disorders as risk factor for subsequent substance abuse: a meta-analysis</article-title><source>J Am Acad Child Adolesc Psychiatry</source><year>2017</year><volume>56</volume><issue>7</issue><fpage>556</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1016/j.jaac.2017.05.004</pub-id><pub-id pub-id-type="pmid">28647007</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Russell</surname><given-names>BS</given-names></name><name name-style="western"><surname>Trudeau</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Leland</surname><given-names>AJ</given-names></name></person-group><article-title>Social influence on adolescent polysubstance use: the escalation to opioid use</article-title><source>Subst Use Misuse</source><year>2015</year><volume>50</volume><issue>10</issue><fpage>1325</fpage><lpage>1331</lpage><pub-id pub-id-type="doi">10.3109/10826084.2015.1013128</pub-id><pub-id pub-id-type="pmid">26442966</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shane</surname><given-names>PA</given-names></name><name name-style="western"><surname>Jasiukaitis</surname><given-names>P</given-names></name><name name-style="western"><surname>Green</surname><given-names>RS</given-names></name></person-group><article-title>Treatment outcomes among adolescents with substance abuse problems: The relationship between comorbidities and post-treatment substance involvement</article-title><source>Eval Program Plann</source><year>2003</year><volume>26</volume><issue>4</issue><fpage>393</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/S0149-7189(03)00055-7</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>KD</given-names></name><name name-style="western"><surname>Lubman</surname><given-names>DI</given-names></name><name name-style="western"><surname>Cosgrave</surname><given-names>EM</given-names></name><name name-style="western"><surname>Killackey</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>HP</given-names></name><name name-style="western"><surname>Hides</surname><given-names>L</given-names></name><etal/></person-group><article-title>Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment</article-title><source>Aust N Z J Psychiatry</source><year>2007</year><volume>41</volume><issue>11</issue><fpage>896</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1080/00048670701634986</pub-id><pub-id pub-id-type="pmid">17924242</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tolliver</surname><given-names>BK</given-names></name><name name-style="western"><surname>Anton</surname><given-names>RF</given-names></name></person-group><article-title>Assessment and treatment of mood disorders in the context of substance abuse</article-title><source>Dialogues Clin Neurosci</source><year>2015</year><volume>17</volume><issue>2</issue><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.31887/DCNS.2015.17.2/btolliver</pub-id><pub-id pub-id-type="pmid">26246792</pub-id><pub-id pub-id-type="pmcid">PMC4518701</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>JD</given-names></name><name name-style="western"><surname>Brown</surname><given-names>ES</given-names></name><name name-style="western"><surname>Rush</surname><given-names>AJ</given-names></name></person-group><article-title>Comorbid disorders in patients with bipolar disorder and concomitant substance dependence</article-title><source>J Affect Disord</source><year>2007</year><volume>102</volume><issue>1&#8211;3</issue><fpage>281</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2007.01.005</pub-id><pub-id pub-id-type="pmid">17291591</pub-id><pub-id pub-id-type="pmcid">PMC2735053</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curran</surname><given-names>GM</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>G</given-names></name><name name-style="western"><surname>Williams</surname><given-names>K</given-names></name><name name-style="western"><surname>Han</surname><given-names>X</given-names></name><name name-style="western"><surname>Allee</surname><given-names>E</given-names></name><name name-style="western"><surname>Kotrla</surname><given-names>KJ</given-names></name></person-group><article-title>The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study</article-title><source>BMC Emerg Med</source><year>2008</year><volume>8</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/1471-227X-8-17</pub-id><pub-id pub-id-type="pmid">19055761</pub-id><pub-id pub-id-type="pmcid">PMC2615439</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Appleby</surname><given-names>L</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>J</given-names></name><name name-style="western"><surname>Amos</surname><given-names>T</given-names></name><name name-style="western"><surname>McDonnell</surname><given-names>R</given-names></name><name name-style="western"><surname>Harris</surname><given-names>C</given-names></name><name name-style="western"><surname>McCann</surname><given-names>K</given-names></name><etal/></person-group><article-title>Suicide within 12 months of contact with mental health services: national clinical survey</article-title><source>BMJ</source><year>1999</year><volume>318</volume><issue>7193</issue><fpage>1235</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1136/bmj.318.7193.1235</pub-id><pub-id pub-id-type="pmid">10231250</pub-id><pub-id pub-id-type="pmcid">PMC27859</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oquendo</surname><given-names>MA</given-names></name><name name-style="western"><surname>Currier</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>SM</given-names></name><name name-style="western"><surname>Hasin</surname><given-names>DS</given-names></name><name name-style="western"><surname>Grant</surname><given-names>BF</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>C</given-names></name></person-group><article-title>Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC)</article-title><source>J Clin Psychiatry</source><year>2010</year><volume>71</volume><issue>7</issue><fpage>902</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.4088/JCP.09m05198gry</pub-id><pub-id pub-id-type="pmid">20667292</pub-id><pub-id pub-id-type="pmcid">PMC2914308</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohnert</surname><given-names>AS</given-names></name><name name-style="western"><surname>Ilgen</surname><given-names>MA</given-names></name><name name-style="western"><surname>Ignacio</surname><given-names>RV</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>JF</given-names></name><name name-style="western"><surname>Valenstein</surname><given-names>M</given-names></name><name name-style="western"><surname>Blow</surname><given-names>FC</given-names></name></person-group><article-title>Risk of death from accidental overdose associated with psychiatric and substance use disorders</article-title><source>Am J Psychiatry</source><year>2012</year><volume>169</volume><issue>1</issue><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2011.10101476</pub-id><pub-id pub-id-type="pmid">21955932</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>TW</given-names></name><name name-style="western"><surname>Lin</surname><given-names>LA</given-names></name><name name-style="western"><surname>Hosanagar</surname><given-names>A</given-names></name><name name-style="western"><surname>Kogowski</surname><given-names>A</given-names></name><name name-style="western"><surname>Paige</surname><given-names>K</given-names></name><name name-style="western"><surname>Bohnert</surname><given-names>AS</given-names></name></person-group><article-title>Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy</article-title><source>J Addict Med</source><year>2016</year><volume>10</volume><issue>6</issue><fpage>369</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1097/ADM.0000000000000245</pub-id><pub-id pub-id-type="pmid">27525471</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yule</surname><given-names>AM</given-names></name><name name-style="western"><surname>Carrellas</surname><given-names>NW</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>M</given-names></name><name name-style="western"><surname>McKowen</surname><given-names>JW</given-names></name><name name-style="western"><surname>Nargiso</surname><given-names>JE</given-names></name><name name-style="western"><surname>Bergman</surname><given-names>BG</given-names></name><etal/></person-group><article-title>Risk factors for overdose in treatment-seeking youth with substance use disorders</article-title><source>J Clin Psychiatry.</source><year>2018</year><pub-id pub-id-type="doi">10.4088/JCP.17m11678</pub-id><pub-id pub-id-type="pmid">29701935</pub-id><pub-id pub-id-type="pmcid">PMC6043357</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilton</surname><given-names>G</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>LA</given-names></name></person-group><article-title>Outcomes of offenders with co-occurring substance use disorders and mental disorders</article-title><source>Psychiatr Serv</source><year>2017</year><volume>68</volume><issue>7</issue><fpage>704</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.201500391</pub-id><pub-id pub-id-type="pmid">28292226</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez</surname><given-names>G</given-names></name><name name-style="western"><surname>Rosenheck</surname><given-names>RA</given-names></name></person-group><article-title>Outcomes and service use among homeless persons with serious mental illness and substance abuse</article-title><source>Psychiatr Serv</source><year>2002</year><volume>53</volume><issue>4</issue><fpage>437</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.53.4.437</pub-id><pub-id pub-id-type="pmid">11919357</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saatcioglu</surname><given-names>O</given-names></name><name name-style="western"><surname>Yapici</surname><given-names>A</given-names></name><name name-style="western"><surname>Cakmak</surname><given-names>D</given-names></name></person-group><article-title>Quality of life, depression and anxiety in alcohol dependence</article-title><source>Drug Alcohol Rev</source><year>2008</year><volume>27</volume><issue>1</issue><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1080/09595230701711140</pub-id><pub-id pub-id-type="pmid">18034385</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kronenberg</surname><given-names>LM</given-names></name><name name-style="western"><surname>Slager-Visscher</surname><given-names>K</given-names></name><name name-style="western"><surname>Goossens</surname><given-names>PJJ</given-names></name><name name-style="western"><surname>van den Brink</surname><given-names>W</given-names></name><name name-style="western"><surname>van Achterberg</surname><given-names>T</given-names></name></person-group><article-title>Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient&#8217;s perspective</article-title><source>BMC Psychiatry</source><year>2014</year><volume>14</volume><issue>1</issue><fpage>264</fpage><pub-id pub-id-type="doi">10.1186/s12888-014-0264-1</pub-id><pub-id pub-id-type="pmid">25234344</pub-id><pub-id pub-id-type="pmcid">PMC4173065</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olfson</surname><given-names>M</given-names></name><name name-style="western"><surname>Shea</surname><given-names>S</given-names></name><name name-style="western"><surname>Feder</surname><given-names>A</given-names></name><name name-style="western"><surname>Fuentes</surname><given-names>M</given-names></name><name name-style="western"><surname>Nomura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gameroff</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice</article-title><source>Arch Fam Med</source><year>2000</year><volume>9</volume><issue>9</issue><fpage>876</fpage><pub-id pub-id-type="doi">10.1001/archfami.9.9.876</pub-id><pub-id pub-id-type="pmid">11031395</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Substance Use and Mental Health Services Administration. 2019 National survey of drug use and health (NSDUH) Releases: U.S. department of health and human services. 2019; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.samhsa.gov/data/release/2019-national-survey-drug-use-and-health-nsduh-releases">https://www.samhsa.gov/data/release/2019-national-survey-drug-use-and-health-nsduh-releases</ext-link>. Accessed 2 Aug. 2022.</mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">National Collaborating Centre for Mental Health (UK). Common mental health disorders: identification and pathways to care. british psychological society (UK). 2011 NICE Clinical Guidelines, No. 123. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK92266/">https://www.ncbi.nlm.nih.gov/books/NBK92266/</ext-link>. Accessed 2 Aug. 2022.<pub-id pub-id-type="pmid">22536621</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">Substance Use and Mental Health Services Administration. white paper on the evidence supporting screening, brief intervention and referral to treatment (SBIRT). 2011. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.samhsa.gov/sites/default/files/sbirtwhitepaper_0.pdf">https://www.samhsa.gov/sites/default/files/sbirtwhitepaper_0.pdf</ext-link>. Accessed 2 Aug. 2022.</mixed-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McNeely</surname><given-names>J</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>PC</given-names></name><name name-style="western"><surname>Rieckmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Sedlander</surname><given-names>E</given-names></name><name name-style="western"><surname>Farkas</surname><given-names>S</given-names></name><name name-style="western"><surname>Chollak</surname><given-names>C</given-names></name><etal/></person-group><article-title>Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff</article-title><source>Addict Sci Clin Pract</source><year>2018</year><volume>13</volume><issue>1</issue><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/s13722-018-0110-8</pub-id><pub-id pub-id-type="pmid">29628018</pub-id><pub-id pub-id-type="pmcid">PMC5890352</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McPherson</surname><given-names>TL</given-names></name><name name-style="western"><surname>Hersch</surname><given-names>RK</given-names></name></person-group><article-title>Brief substance use screening instruments for primary care settings: a review</article-title><source>J Subst Abuse Treat</source><year>2000</year><volume>18</volume><issue>2</issue><fpage>193</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/s0740-5472(99)00028-8</pub-id><pub-id pub-id-type="pmid">10716103</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pilowsky</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L-T</given-names></name></person-group><article-title>Screening for alcohol and drug use disorders among adults in primary care: a review</article-title><source>Subst Abuse Rehabil</source><year>2012</year><volume>3</volume><fpage>25</fpage><pub-id pub-id-type="doi">10.2147/SAR.S30057</pub-id><pub-id pub-id-type="pmid">22553426</pub-id><pub-id pub-id-type="pmcid">PMC3339489</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahm</surname><given-names>AK</given-names></name><name name-style="western"><surname>Boggs</surname><given-names>JM</given-names></name><name name-style="western"><surname>Martin</surname><given-names>C</given-names></name><name name-style="western"><surname>Price</surname><given-names>DW</given-names></name><name name-style="western"><surname>Beck</surname><given-names>A</given-names></name><name name-style="western"><surname>Backer</surname><given-names>TE</given-names></name><etal/></person-group><article-title>Facilitators and barriers to implementing screening, brief intervention, and referral to treatment (SBIRT) in primary care in integrated health care settings</article-title><source>Subst Abus</source><year>2015</year><volume>36</volume><issue>3</issue><fpage>281</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1080/08897077.2014.951140</pub-id><pub-id pub-id-type="pmid">25127073</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paris</surname><given-names>M</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Hoge</surname><given-names>MA</given-names></name></person-group><article-title>Burnout in the mental health workforce: a review</article-title><source>J Behav Health Serv Res</source><year>2010</year><volume>37</volume><issue>4</issue><fpage>519</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1007/s11414-009-9202-2</pub-id><pub-id pub-id-type="pmid">20013066</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woltmann</surname><given-names>EM</given-names></name><name name-style="western"><surname>Whitley</surname><given-names>R</given-names></name><name name-style="western"><surname>McHugo</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Brunette</surname><given-names>M</given-names></name><name name-style="western"><surname>Torrey</surname><given-names>WC</given-names></name><name name-style="western"><surname>Coots</surname><given-names>L</given-names></name><etal/></person-group><article-title>The role of staff turnover in the implementation of evidence-based practices in mental health care</article-title><source>Psychiatr Serv</source><year>2008</year><volume>59</volume><issue>7</issue><fpage>732</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1176/ps.2008.59.7.732</pub-id><pub-id pub-id-type="pmid">18586989</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabel</surname><given-names>S</given-names></name><name name-style="western"><surname>Radigan</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Sederer</surname><given-names>LI</given-names></name></person-group><article-title>Health monitoring and promotion among youths with psychiatric disorders: program development and initial findings</article-title><source>Psychiatr Serv</source><year>2011</year><volume>62</volume><issue>11</issue><fpage>1331</fpage><lpage>1337</lpage><pub-id pub-id-type="doi">10.1176/ps.62.11.pss6211_1331</pub-id><pub-id pub-id-type="pmid">22211213</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karno</surname><given-names>M</given-names></name><name name-style="western"><surname>Granholm</surname><given-names>E</given-names></name><name name-style="western"><surname>Lin</surname><given-names>A</given-names></name></person-group><article-title>Factor structure of the alcohol use disorders identification test (audit) in a mental health clinic sample</article-title><source>J Stud Alcohol</source><year>2000</year><volume>61</volume><issue>5</issue><fpage>751</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.15288/jsa.2000.61.751</pub-id><pub-id pub-id-type="pmid">11022816</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">King PR, Beehler GP, Wade M, Buchholz LJ, Funderburk JS, Lilienthal KR, et al. 2018. Opportunities to improve measurement based care practices in mental health care systems a case example of electronic mental health screening and measurement. Fam Syst Health. 10.1037/fsh0000379<pub-id pub-id-type="doi" assigning-authority="pmc">10.1037/fsh0000379</pub-id><pub-id pub-id-type="pmid">30589320</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramo</surname><given-names>DE</given-names></name><name name-style="western"><surname>Bahorik</surname><given-names>AL</given-names></name><name name-style="western"><surname>Delucchi</surname><given-names>KL</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>CI</given-names></name><name name-style="western"><surname>Satre</surname><given-names>DD</given-names></name></person-group><article-title>Alcohol and drug use, pain and psychiatric symptoms among adults seeking outpatient psychiatric treatment: latent class patterns and relationship to health status</article-title><source>J Psychoactive Drugs</source><year>2018</year><volume>50</volume><issue>1</issue><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1080/02791072.2017.1401185</pub-id><pub-id pub-id-type="pmid">29199899</pub-id><pub-id pub-id-type="pmcid">PMC5933843</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satre</surname><given-names>D</given-names></name><name name-style="western"><surname>Wolfe</surname><given-names>W</given-names></name><name name-style="western"><surname>Eisendrath</surname><given-names>S</given-names></name><name name-style="western"><surname>Weisner</surname><given-names>C</given-names></name></person-group><article-title>Computerized screening for alcohol and drug use among adults seeking outpatient psychiatric services</article-title><source>Psychiatr Serv</source><year>2008</year><volume>59</volume><issue>4</issue><fpage>441</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1176/ps.2008.59.4.441</pub-id><pub-id pub-id-type="pmid">18378846</pub-id><pub-id pub-id-type="pmcid">PMC3659170</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silverman</surname><given-names>DC</given-names></name><name name-style="western"><surname>O'Neill</surname><given-names>SF</given-names></name><name name-style="western"><surname>Cleary</surname><given-names>PD</given-names></name><name name-style="western"><surname>Barwick</surname><given-names>C</given-names></name><name name-style="western"><surname>Joseph</surname><given-names>R</given-names></name></person-group><article-title>Recognition of alcohol abuse in psychiatric outpatients and its effect on treatment</article-title><source>Psychiatr Serv</source><year>1992</year><volume>43</volume><issue>6</issue><fpage>644</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1176/ps.43.6.644</pub-id><pub-id pub-id-type="pmid">1601411</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denering</surname><given-names>LL</given-names></name><name name-style="western"><surname>Spear</surname><given-names>SE</given-names></name></person-group><article-title>Routine use of screening and brief intervention for college students in a university counseling center</article-title><source>J Psychoactive Drugs</source><year>2012</year><volume>44</volume><issue>4</issue><fpage>318</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1080/02791072.2012.718647</pub-id><pub-id pub-id-type="pmid">23210380</pub-id><pub-id pub-id-type="pmcid">PMC3518854</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stanhope</surname><given-names>V</given-names></name><name name-style="western"><surname>Manuel</surname><given-names>JI</given-names></name><name name-style="western"><surname>Jessell</surname><given-names>L</given-names></name><name name-style="western"><surname>Halliday</surname><given-names>TM</given-names></name></person-group><article-title>Implementing SBIRT for adolescents within community mental health organizations: a mixed methods study</article-title><source>J Subst Abuse Treat</source><year>2018</year><volume>90</volume><fpage>38</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2018.04.009</pub-id><pub-id pub-id-type="pmid">29866382</pub-id><pub-id pub-id-type="pmcid">PMC6482825</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>WM</given-names></name><name name-style="western"><surname>Restar</surname><given-names>A</given-names></name><name name-style="western"><surname>Operario</surname><given-names>D</given-names></name></person-group><article-title>Exploring multiple forms of intimate partner violence in a gender and racially/ethnically diverse sample of transgender adults</article-title><source>J Interpers Violence</source><year>2021</year><volume>36</volume><issue>19&#8211;20</issue><fpage>10477</fpage><lpage>10498</lpage><pub-id pub-id-type="doi">10.1177/0886260519876024</pub-id><pub-id pub-id-type="pmid">31526070</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bush</surname><given-names>K</given-names></name><name name-style="western"><surname>Kivlahan</surname><given-names>DR</given-names></name><name name-style="western"><surname>McDonell</surname><given-names>MB</given-names></name><name name-style="western"><surname>Fihn</surname><given-names>SD</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>KA</given-names></name><collab>Project ACQI</collab></person-group><article-title>The AUDIT alcohol consumption questions (AUDIT-C) an effective brief screening test for problem drinking</article-title><source>Arch Intern Med</source><year>1998</year><pub-id pub-id-type="doi">10.1001/archinte.158.16.1789</pub-id><pub-id pub-id-type="pmid">9738608</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knight</surname><given-names>JR</given-names></name><name name-style="western"><surname>Sherritt</surname><given-names>L</given-names></name><name name-style="western"><surname>Shrier</surname><given-names>LA</given-names></name><name name-style="western"><surname>Harris</surname><given-names>SK</given-names></name><name name-style="western"><surname>Chang</surname><given-names>G</given-names></name></person-group><article-title>Validity of the CRAFFT substance abuse screening test among adolescent clinic patients</article-title><source>Arch Pediatr Adolesc Med</source><year>2002</year><volume>156</volume><issue>6</issue><fpage>607</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1001/archpedi.156.6.607</pub-id><pub-id pub-id-type="pmid">12038895</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>WHO Assist Working Group</collab></person-group><article-title>The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility</article-title><source>Addiction</source><year>2002</year><volume>97</volume><issue>9</issue><fpage>1183</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1046/j.1360-0443.2002.00185.x</pub-id><pub-id pub-id-type="pmid">12199834</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selzer</surname><given-names>ML</given-names></name><name name-style="western"><surname>Vinokur</surname><given-names>A</given-names></name><name name-style="western"><surname>van Rooijen</surname><given-names>L</given-names></name></person-group><article-title>A self-administered short Michigan alcoholism screening test (SMAST)</article-title><source>J Stud Alcohol</source><year>1975</year><volume>36</volume><issue>1</issue><fpage>117</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.15288/jsa.1975.36.117</pub-id><pub-id pub-id-type="pmid">238068</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McNeely</surname><given-names>J</given-names></name><name name-style="western"><surname>Adam</surname><given-names>A</given-names></name><name name-style="western"><surname>Rotrosen</surname><given-names>J</given-names></name><name name-style="western"><surname>Wakeman</surname><given-names>SE</given-names></name><name name-style="western"><surname>Wilens</surname><given-names>TE</given-names></name><name name-style="western"><surname>Kannry</surname><given-names>J</given-names></name><etal/></person-group><article-title>Comparison of methods for alcohol and drug screening in primary care clinics</article-title><source>JAMA Netw Open.</source><year>2021</year><volume>4</volume><issue>5</issue><fpage>e2110721</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.10721</pub-id><pub-id pub-id-type="pmid">34014326</pub-id><pub-id pub-id-type="pmcid">PMC8138691</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Substance Abuse and Mental Health Services Administration. National Mental Health Services Survey (N-MHSS) 2020 data on mental health treatment facilities. 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.samhsa.gov/data/report/national-mental-health-services-survey-n-mhss-2020-data-mental-health-treatment-facilities">https://www.samhsa.gov/data/report/national-mental-health-services-survey-n-mhss-2020-data-mental-health-treatment-facilities</ext-link>. Accessed 2 Aug. 2022.</mixed-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sundstr&#246;m</surname><given-names>C</given-names></name><name name-style="western"><surname>Peters&#233;n</surname><given-names>E</given-names></name><name name-style="western"><surname>Sinadinovic</surname><given-names>K</given-names></name><name name-style="western"><surname>Gustafsson</surname><given-names>P</given-names></name><name name-style="western"><surname>Berman</surname><given-names>AH</given-names></name></person-group><article-title>Identification and management of alcohol use and illicit substance use in outpatient psychiatric clinics in Sweden: a national survey of clinic directors and staff</article-title><source>Addict Sci Clin Pract</source><year>2019</year><volume>14</volume><issue>1</issue><fpage>10</fpage><pub-id pub-id-type="doi">10.1186/s13722-019-0140-x</pub-id><pub-id pub-id-type="pmid">30841916</pub-id><pub-id pub-id-type="pmcid">PMC6404264</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adam</surname><given-names>A</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>RP</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L-T</given-names></name><name name-style="western"><surname>Subramaniam</surname><given-names>G</given-names></name><name name-style="western"><surname>Laska</surname><given-names>E</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>G</given-names></name><etal/></person-group><article-title>Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool</article-title><source>Addict Sci Clin Pract</source><year>2019</year><volume>14</volume><issue>1</issue><fpage>39</fpage><pub-id pub-id-type="doi">10.1186/s13722-019-0167-z</pub-id><pub-id pub-id-type="pmid">31615549</pub-id><pub-id pub-id-type="pmcid">PMC6794766</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spencer</surname><given-names>M</given-names></name><name name-style="western"><surname>Warner</surname><given-names>M</given-names></name><name name-style="western"><surname>Bastian</surname><given-names>BA</given-names></name><name name-style="western"><surname>Trinidad</surname><given-names>JP</given-names></name><name name-style="western"><surname>Hedegaard</surname><given-names>H</given-names></name></person-group><article-title>Drug overdose deaths involving fentanyl, 2011&#8211;2016</article-title><source>Natl Vital Stat Rep</source><year>2019</year><volume>68</volume><issue>3</issue><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">31112123</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chisolm</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>W</given-names></name><name name-style="western"><surname>Julian</surname><given-names>T</given-names></name><name name-style="western"><surname>Kelleher</surname><given-names>KJ</given-names></name></person-group><article-title>Adolescent satisfaction with computer-assisted behavioural risk screening in primary care</article-title><source>Child Adolesc Ment Health</source><year>2008</year><volume>13</volume><issue>4</issue><fpage>163</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1111/j.1475-3588.2007.00474.x</pub-id><pub-id pub-id-type="pmid">19779573</pub-id><pub-id pub-id-type="pmcid">PMC2750090</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paperny</surname><given-names>DM</given-names></name><name name-style="western"><surname>Aono</surname><given-names>JY</given-names></name><name name-style="western"><surname>Lehman</surname><given-names>RM</given-names></name><name name-style="western"><surname>Hammar</surname><given-names>SL</given-names></name><name name-style="western"><surname>Risser</surname><given-names>J</given-names></name></person-group><article-title>Computer-assisted detection and intervention in adolescent high-risk health behaviors</article-title><source>J Pediatr</source><year>1990</year><volume>116</volume><issue>3</issue><fpage>456</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/s0022-3476(05)82844-6</pub-id><pub-id pub-id-type="pmid">2308041</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rhodes</surname><given-names>KV</given-names></name><name name-style="western"><surname>Lauderdale</surname><given-names>DS</given-names></name><name name-style="western"><surname>Stocking</surname><given-names>CB</given-names></name><name name-style="western"><surname>Howes</surname><given-names>DS</given-names></name><name name-style="western"><surname>Roizen</surname><given-names>MF</given-names></name><name name-style="western"><surname>Levinson</surname><given-names>W</given-names></name></person-group><article-title>Better health while you wait: a controlled trial of a computer-based intervention for screening and health promotion in the emergency department</article-title><source>Ann Emerg Med</source><year>2001</year><volume>37</volume><issue>3</issue><fpage>284</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1067/mem.2001.110818</pub-id><pub-id pub-id-type="pmid">11223765</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jimenez</surname><given-names>DE</given-names></name><name name-style="western"><surname>Bartels</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Cardenas</surname><given-names>V</given-names></name><name name-style="western"><surname>Alegr&#237;a</surname><given-names>M</given-names></name></person-group><article-title>Stigmatizing attitudes toward mental illness among racial/ethnic older adults in primary care</article-title><source>Int J Geriatr Psychiatry</source><year>2013</year><volume>28</volume><issue>10</issue><fpage>1061</fpage><lpage>1068</lpage><pub-id pub-id-type="doi">10.1002/gps.3928</pub-id><pub-id pub-id-type="pmid">23361866</pub-id><pub-id pub-id-type="pmcid">PMC3672370</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Small</surname><given-names>J</given-names></name><name name-style="western"><surname>Curran</surname><given-names>GM</given-names></name><name name-style="western"><surname>Booth</surname><given-names>B</given-names></name></person-group><article-title>Barriers and facilitators for alcohol treatment for women: are there more or less for rural women?</article-title><source>J Subst Abuse Treat</source><year>2010</year><volume>39</volume><issue>1</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2010.03.002</pub-id><pub-id pub-id-type="pmid">20381284</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meirte</surname><given-names>J</given-names></name><name name-style="western"><surname>Hellemans</surname><given-names>N</given-names></name><name name-style="western"><surname>Anthonissen</surname><given-names>M</given-names></name><name name-style="western"><surname>Denteneer</surname><given-names>L</given-names></name><name name-style="western"><surname>Maertens</surname><given-names>K</given-names></name><name name-style="western"><surname>Moortgat</surname><given-names>P</given-names></name><etal/></person-group><article-title>Benefits and disadvantages of electronic patient-reported outcome measures: systematic review</article-title><source>JMIR Perioper Med.</source><year>2020</year><volume>3</volume><issue>1</issue><fpage>e15588</fpage><pub-id pub-id-type="doi">10.2196/15588</pub-id><pub-id pub-id-type="pmid">33393920</pub-id><pub-id pub-id-type="pmcid">PMC7709853</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sisodia</surname><given-names>RC</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>JA</given-names></name><name name-style="western"><surname>Sequist</surname><given-names>TD</given-names></name></person-group><article-title>Digital disparities: lessons learned from a patient reported outcomes program during the COVID-19 pandemic</article-title><source>JAMIA Open</source><year>2021</year><volume>28</volume><issue>10</issue><fpage>2265</fpage><lpage>2268</lpage><pub-id pub-id-type="doi">10.1093/jamia/ocab138</pub-id><pub-id pub-id-type="pmcid">PMC8344913</pub-id><pub-id pub-id-type="pmid">34244760</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Earnshaw</surname><given-names>VA</given-names></name><name name-style="western"><surname>Bogart</surname><given-names>LM</given-names></name><name name-style="western"><surname>Menino</surname><given-names>DD</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>JF</given-names></name><name name-style="western"><surname>Chaudoir</surname><given-names>SR</given-names></name><name name-style="western"><surname>Reed</surname><given-names>NM</given-names></name><etal/></person-group><article-title>Disclosure, stigma, and social support among young people receiving treatment for substance use disorders and their caregivers: a qualitative analysis</article-title><source>Int J Ment Health Addict</source><year>2019</year><volume>17</volume><issue>6</issue><fpage>1535</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.1007/s11469-018-9930-8</pub-id><pub-id pub-id-type="pmid">33312084</pub-id><pub-id pub-id-type="pmcid">PMC7731618</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>JF</given-names></name><name name-style="western"><surname>Greene</surname><given-names>MC</given-names></name><name name-style="western"><surname>Abry</surname><given-names>A</given-names></name></person-group><article-title>A US national randomized study to guide how best to reduce stigma when describing drug-related impairment in practice and policy</article-title><source>Addiction</source><year>2021</year><volume>116</volume><issue>7</issue><fpage>1757</fpage><lpage>1767</lpage><pub-id pub-id-type="doi">10.1111/add.15333</pub-id><pub-id pub-id-type="pmid">33197084</pub-id><pub-id pub-id-type="pmcid">PMC8124079</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>KM</given-names></name><name name-style="western"><surname>Harris</surname><given-names>SK</given-names></name><name name-style="western"><surname>Shrier</surname><given-names>LA</given-names></name><name name-style="western"><surname>Bukstein</surname><given-names>OG</given-names></name></person-group><article-title>Measurement-based care in the treatment of adolescents with substance use disorders</article-title><source>Child Adolesc Psychiatr Clin N Am</source><year>2020</year><volume>29</volume><issue>4</issue><fpage>675</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1016/j.chc.2020.06.006</pub-id><pub-id pub-id-type="pmid">32891369</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fadus</surname><given-names>MC</given-names></name><name name-style="western"><surname>Squeglia</surname><given-names>LM</given-names></name><name name-style="western"><surname>Valadez</surname><given-names>EA</given-names></name><name name-style="western"><surname>Tomko</surname><given-names>RL</given-names></name><name name-style="western"><surname>Bryant</surname><given-names>BE</given-names></name><name name-style="western"><surname>Gray</surname><given-names>KM</given-names></name></person-group><article-title>Adolescent substance use disorder treatment: an update on evidence-based strategies</article-title><source>Curr Psychiatry Rep</source><year>2019</year><volume>21</volume><issue>10</issue><fpage>96</fpage><pub-id pub-id-type="doi">10.1007/s11920-019-1086-0</pub-id><pub-id pub-id-type="pmid">31522280</pub-id><pub-id pub-id-type="pmcid">PMC7241222</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Horn</surname><given-names>DHA</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>J</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>KG</given-names></name><name name-style="western"><surname>Bonn-Miller</surname><given-names>MO</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>T</given-names></name><name name-style="western"><surname>Del Re</surname><given-names>AC</given-names></name><etal/></person-group><article-title>The predictive validity of the progress assessment, a clinician administered instrument for use in measurement-based care for substance use disorders</article-title><source>Psychiatry Res</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.psychres.2020.113282</pub-id><pub-id pub-id-type="pmid">32711168</pub-id><pub-id pub-id-type="pmcid">PMC9434595</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="other">Substance Abuse and Mental Health Services Administration. TIP 42: Substance use disorder treatment for people with co-occurring disorders. 2020; 42. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://store.samhsa.gov/product/tip-42-substance-use-treatment-persons-co-occurring-disorders/PEP20-02-01-004">https://store.samhsa.gov/product/tip-42-substance-use-treatment-persons-co-occurring-disorders/PEP20-02-01-004</ext-link>. Accessed 28 July 2022.<pub-id pub-id-type="pmid">34106563</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gagnier</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Lai</surname><given-names>J</given-names></name><name name-style="western"><surname>Mokkink</surname><given-names>LB</given-names></name><name name-style="western"><surname>Terwee</surname><given-names>CB</given-names></name></person-group><article-title>COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures</article-title><source>Qual Life Res</source><year>2021</year><pub-id pub-id-type="doi">10.1007/s11136-021-02822-4</pub-id><pub-id pub-id-type="pmid">33818733</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>